Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They need to fill the seat for now just for voting purposes.
Could be the opposite.
Sarma looks more like a placeholder until they’re ready to sell the company or reconfigure the board to accommodate a partner(s).
It would be interesting to see a markup to show and compare exactly what was edited from the first complaint. But if the substance of the R&R wasn’t fully addressed per your comments below about the table, then the MTD is still an uphill battle.
Agreed, the overall analysis seems sufficient to move past the MTD, but I thought that the last time as well.
In any event, it’s back to square one and on to square two.
That data s still a bit of stinking mess for 2 reasons. They still have a future close date listed as a spoof in the previous 20 days. On the 7/2/18 exchange they assert the close on 8/1/18 effected the price. But worse, they include any date regardless of it being one of the lowest 5. If the spoof was not one of the lowest 5 it would have no effect in the sale price.
Overall I would expect the next MTD to be dismissed. There will be some yapping about exhibit 6 though. And perhaps some shots about changed assertions.
On very quick read, the amended complaint is more analytical and seems to be more straightforward in making their argument, especially in drawing the connection between showing a higher percentage of unexecuted sell orders that preceded buy orders, compared to normal trading.
I know, there aren’t.
Waiting plays into the hands of the defendants, who are otherwise happy enough to drag this case out for years, short of a settlement that make sense for them.
Waiting for new legal precedent when there are no relevant Federal cases that are pending a ruling for a related matter is nonsense as well.
One reason to wait is in the event there are ongoing settlement negotiations. Waiting to make sure there are no typos is nonsense.
No, but I know you ;)
I guess it’s that old trusted legal strategy of winning by losing your MTD.
Saw that on TV once — on that show Law & Order SUV.
Call me crazy, but rather see a higher stock price.
I know, I’m a heretic for even suggesting that.
CM is having a difficult time proving loss causation as evidenced by the fact that the MTD was granted. Can’t imagine how difficult it will be to prove intent (albeit not absolutely required, but still important) and spoofing per the letter of the law when all the other more nuanced factors come into play, including the highly technical aspects of HFT.
Wasn’t it Posner who commented that this complaint is testing new case law, or something along those lines?
I’ve advocated for a settlement from the beginning, since the utility to shareholders was greatest last year, which will diminishes over time. Even a modest settlement last year may have fully funded the company for a year and to led nearly no dilution that would have stabilized the stock price.
Now that presupposes any of the marker makers would be willing to settle early in the lawsuit. Maybe they’re just happy to play this out for as long as possible? But this litigation is very expensive, involving over 30 or more highly paid attorneys (hourly rates > $1,000) from like 6 or 7 different law firms.
Agree. It may be a long road if they do not settle.
This of course begs the question: where are all the derivative lawsuits against these market makers if the spoofing case is so strong? In any event, amending and re-filing the complaint puts everyone back to square one.
From the perspective of NWBO shareholders and valuation of our investment, this is a non-factor. Maybe from a market integrity perspective, this case could be important. But still years from getting to that point, if ever.
this spoofing case (and other manipulation cases) will remain an important and significant case in its own right, and definitely worth pursuing to the end.
FT is probably the best business oriented newspaper in the world. Much better than the WSJ, which has gone way down hill for obvious reasons.
Liked the article, and fairly consistent with points made here. The root cause isn’t spoofing per se, it’s the high frequency trading that’s largely unregulated. HFT is trading in ways that are impossible for humans to execute on their own, and the regs just haven’t caught up with what’s rules govern the algorithms.
Not obvious to me that NWBO will be able to overcome the deficiencies that led to the granting of the MTD in the first place. But it’s more or less a side show anyway, since by the time it takes this case to progress to a point where there might be a settlement, all the milestones (i.e., RA submissions, approvals, uplisting, partnerships, etc.,) that impact the business will be already determined, one way or another.
When issues arise over weaknesses in internal controls, it’s not unusual for the general counsel to sign the SEC disclosure. I believe the thought is that under the circumstance you don’t want the same person responsible for the internal control weakness (i.e., the CFO) being the same person certifying the accuracy and completeness of the disclosure.
I chased him down, but my net was too small.
Anyone catch Dr Ashkan today?
The song is about a bad breakup with Beatty Crocker.
Yes, the Gorky Park Bench. Not to be confused with the MacArthur Park Bench where someone left their cake out in rain.
I know one sleeper cell in Moscow goes by the code name NWBO Stock Price,
He is Board Certified oncologist. Say what you want about me, but Alpha deserves some respect regardless of whether someone agrees or disagree with his views. His day is spent treating cancer patient. Let that sink in.
Look, Alph, I’m a business professional and you’re an oncologist. My investment in NWBO from a professional perspective is the same as if you decided to live on a study diet of bacon burghers washed down with a daily glass of red dye #2. We both know better.
Having said that, keep the faith — I do believe this will work out. Maybe not at the level we had hoped given the length of time we’ve invested, but at least at some meaningful return. The hour glass is now turned with the submission, so something has to happen by summer, one way or the other.
I’ve made this point many times over the years: the biggest problem for shareholders is that the stock is traded as an OTC. That limits institutional investment. I could list ten other reasons why it only takes loose change to buy a share of NWBO. But I’ll demure.
It’s very uncommon for an OTC stock not listed on an another major foreign exchange to have market caps exceeding $ billion — NWBO’s market cap is actually very good for an OTC stock, but the dilution doesn’t allow that to be reflected in the stock price. Note: The Frankfurt exchanged that NWBO is listed is the German version of their OTC.
Let’s also be clear, the MTD for the spoofing case has been granted for the time being. Not clear the case will survive at all.
It’s a minefield on this message board.
Anytime an insider sells shares it always raises questions. The one silver lining is that he couldn’t sell on any insider information that was materially negative. My guess is there was no certain news at the time of the sale. And we don’t know his own personal financial situation or strategy to speculate on his motive as to why he didn’t use other resources to pay his taxes.
When it comes to insider sales, typically you want to consider how often and how many insiders. One insider one time is not terribly alarming. NVCR on the other hand had multiple insiders selling multiple times — everyone should have known where that was headed.
One of the very few times I agree with you, even going back to your private message boards.
The difficulty and risk with franchising a process is quality control and malpractice exposure, not to mention all the manufacturing licenses required and trained technicians that need to be hired and dispersed presumably around the globe. And for at least the present, this is just an orphan indication, so there’s no economies of scale that a franchise can benefit.
Another positive take away from the emailed letter w/ the PR attached that Innis sent me this morning is that I doubt the company would engage in negotiations with a vendor for an equipment manufacturing contract unless they were more or less confident with approval. Although, there are likely contingencies built into a pending contract in the event that everything doesn’t go according to plan.
Thanks. Thought it was a bit odd that Innis would just send to me, or perhaps just some of the larger shareholders?
See, that’s such a dead give away that your Hoffy.
Cut and paste at will on Twitter…hahahah!!!
I credit my cut and paste skills to you, Sensei.
Was busy reading the nice email that Innis sent to my inbox. Did he just send it to me or did he copy all message board posters?
February 6, 2024
Dear Poorman
We are very pleased to send to you our most recent news release attached below. Since the purchase of Flaskworks in 2020, there has been a tremendous amount of work to develop a “closed” system capable of carrying out the same manufacturing process, and producing the same finished DCVax-L product, as our current manual system at our Sawston, UK facility. The attached release announces the milestone of achieving this goal and discusses its potential benefits along with a brief description of our expanding patent coverage.
Congratulations to the entire Flaskworks team for their achievements, as well as to the teams at Advent BioServices and Northwest Biotherapeutics for their contributions.
Best,
?
Dave Innes
VP, Investor Relations
Northwest Bio?therapeutics, Inc.
Hahaha.
Right. You’re the best cut and paste legal beagle (beagle, not eagle) of all time.
Might I suggest another alias for you: “Cut’n_Paste.”
I know you’re worried. It’s just a matter of time. When I’m ready to pull the trigger I will.
Crash, this was one of the better written press releases.
Happy, I believe you’re actually working as an influencer, and I suspect post under another well known alias. Essentially an imposter.
Nobody would say I’m not posting because I can’t enforce someone else’s silly bet, nor try to misrepresent what I said was a goof to one very gullible individual in a private message unless they have an ulterior motive. What’s your motive lady?
The management of NWBO has been so ineffectual and troubling that if you didn’t know better, you would think they were deliberately undermining their own company. I don’t believe that’s actually the case, but the same end result.
I rather work a Wendy’s. I like their burgers.
You know how many shares I own.
I can’t afford anymore….if this goes bust, that Walmart job will be in my future,
Crash, I had to throw out that case of Old Crow — it didn’t age well.
Fingers crossed.
So, are you saying less than 150 days?
My concern is the erosion and mishandling of that value.
Make me feel good about that…
Apples and oranges.
But I’ll settle for a ham sandwich at this point.
Okay, let me ask the question a different way —
Are you okay with the stock price at 53 cents per share?
Be careful that you’re not friends with shareholders who are also limited partners in Toucan. The alignment is totally off. That’s just my free advice for today. I’m off the board until this evening.
Dude, it’s coming :)